Pathology Doctors in Greenwich, CT Accepting Medicare

5 Pathology doctors found. Showing 1 - 5

Eric J Diamond, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 5 Perryridge Rd, Pathology Department, Greenwich, CT 06830 Phone: 203-863-3061    Fax: 203-863-3846

Stephen R Gray, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 5 Perryridge Rd, Pathology Department, Greenwich, CT 06830 Phone: 203-863-3061    Fax: 203-863-3846

Dr. Tamara Handerson, MD Pathology - Anatomic Pathology Medicare: Accepting Medicare Assignments Practice Location: 5 Perryridge Rd, Department Of Pathology, Greenwich, CT 06830 Phone: 203-863-3927

Vicki L Altmeyer, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 5 Perryridge Rd, Pathology Department, Greenwich, CT 06830 Phone: 203-863-3061    Fax: 203-863-3846

Ileana Green, MD Pathology - Anatomic Pathology Medicare: Accepting Medicare Assignments Practice Location: 5 Perryridge Rd, Pathology Dept., Greenwich, CT 06830 Phone: 203-863-3061    Fax: 203-863-3846

News Archive

Researchers identify normal movement mechanisms of PrPC in brain

Researchers at the University of California, San Diego School of Medicine have identified the motors that move non-infectious prion proteins (PrPC) - found within many mammalian cells - up and down long, neuronal transport pathways.

Patients with malignant gastrointestinal disease show high prevalence of malnutrition

Malnutrition is an important factor, influencing both morbidity and recovery after surgery. The early detection of nutritional risk would allow early intervention, which may prevent later complications. A traditional nutritional assessment often includes dietary and medical evaluations to identify significant weight loss over time, significantly low or high body weight(BW), skinfold thickness, serum nutritional factor levels and functional measurements of muscle strength.

AcelRx Pharmaceuticals' Zalviso device gets CE Mark approval

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today announced that it has received CE Mark approval (Conformite Europeenne) for the Zalviso device.

New protein discovery could help develop intracellular biologic drugs

Permeon Biologics, a biopharmaceutical company pioneering a novel class of intracellular protein biologics, today announced the discovery of an entirely new class of naturally occurring human supercharged proteins called Intraphilins-.

Read more Medical News

› Verified 8 days ago